About Elucigene
Elucigene is a company based in Manchester (United Kingdom) founded in 2013 was acquired by Yourgene Health in April 2019.. The company has 180 employees as of March 31, 2021. Elucigene offers products and services including IONA® Test, Ranger® Technology, and NGS Solutions. Elucigene operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and NeuMoDx, among others.
- Headquarter Manchester, United Kingdom
- Employees 180 as on 31 Mar, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Delta Diagnostics (Uk) Ltd
- Date of Incorporation 18 Sep, 2013
- Jurisdiction MANCHESTER
-
Annual Revenue
$896.25 K (USD)-83as on Mar 31, 2021
-
Net Profit
$-521.48 K (USD)-133as on Mar 31, 2021
-
EBITDA
-
Latest Funding Round
$263 K (USD), Grant
Oct 05, 2014
- Investors
-
Employee Count
180
as on Mar 31, 2021
-
Acquired by
Yourgene Health
(Apr 17, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elucigene
Elucigene offers a comprehensive portfolio of products and services, including IONA® Test, Ranger® Technology, and NGS Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive test for detecting fetal chromosomal abnormalities in pregnant women.
Automated platform for precise DNA enrichment in clinical and research applications.
Tools for next-generation sequencing in reproductive health and precision medicine.
Funding Insights of Elucigene
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $263,000
-
First Round
First Round
(05 Oct 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2014 | Amount | Grant - Elucigene | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Elucigene
Elucigene has secured backing from 1 investor. Prominent investors backing the company include Yourgene Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Non-invasive prenatal genetic tests and genomic services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Elucigene
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Elucigene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Elucigene Comparisons
Competitors of Elucigene
Elucigene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and NeuMoDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Elucigene
When was Elucigene founded?
Elucigene was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Elucigene located?
Elucigene is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Who is the current CEO of Elucigene?
Mark Street-Docherty is the current CEO of Elucigene.
How many employees does Elucigene have?
As of Mar 31, 2021, the latest employee count at Elucigene is 180.
What is the annual revenue of Elucigene?
Annual revenue of Elucigene is $896.25K as on Mar 31, 2021.
What does Elucigene do?
Elucigene was founded in 2013 in Manchester, United Kingdom, as a provider of in vitro diagnostics focused on cystic fibrosis and various genetic conditions. Operations center on the use of ARMS, a specialized PCR technique, for precise identification of single nucleotide variations. Assays are developed for cystic fibrosis, reproductive health, aneuploidy detection, and additional genetic disorders, supporting clinical applications in genetics.
Who are the top competitors of Elucigene?
Elucigene's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does Elucigene offer?
Elucigene offers IONA® Test, Ranger® Technology, and NGS Solutions.
Who are Elucigene's investors?
Elucigene has 1 investor. Key investors include Yourgene Health.